ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014

Block, Committee Agree; No New PDQ For General Public

January 11, 1985

Cancer Surveillance: risk Factors Explain SF Breast Cancer Rates

July 25, 1997

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003